首页|氟比洛芬酯联合纳布啡超前镇痛在腹腔镜胆囊切除术中的应用

氟比洛芬酯联合纳布啡超前镇痛在腹腔镜胆囊切除术中的应用

Application of Flurbiprofen Axetil Combined with Nalbuphine Preemptiue Analgesia in Laparoscopic Cholecystectomy

扫码查看
目的 评价氟比洛芬酯联合纳布啡超前镇痛应用于腹腔镜胆囊切除术(laparoscopic cholecystectomy,LC)中的临床效果.方法 回顾性选取2022年8月—2023年10月于洛阳市中心医院接受LC的90例患者的临床资料,依据麻醉药物的不同分为纳布啡组(A组,n=30)、氟比洛芬酯组(B组,n=30)和纳布啡联合氟比洛芬酯组(C组,n=30).手术切皮前15 min给予超前镇痛药物,A组患者静脉输注纳布啡0.2 mg/kg,B组患者静脉输注氟比洛芬酯2 mg/kg,C组静脉输注纳布啡0.2 mg/kg和氟比洛芬酯2 mg/kg,比较3组患者术后2 h(T1)、术后4 h(T2)、术后12 h(T3)及术后24 h(T4)的视觉模拟评分法(Visual Analogue Scale,VAS)评分,Ramsay镇静评分,手术中使用丙泊酚和瑞芬太尼的剂量、停用药物后的苏醒时间、术后恢复质量评分[采用15项恢复质量(Quality of Recovery-15 Score,QoR-15)量表评估]、术后不良反应发生情况.结果 3组患者丙泊酚用量、苏醒时间比较,差异无统计学意义(P均>0.05);C组患者瑞芬太尼用量低于A组和B组,差异有统计学意义(P<0.05).C组患者T1、T2时间点VAS评分低于A组和B组,差异有统计学意义(P均<0.05);3组患者T3、T4时间点VAS评分比较,差异无统计学意义(P均>0.05).3组患者T1~T4时间点的Ramsay评分比较,差异无统计学意义(P均>0.05).C组患者术后第1天和术后第3天QoR-15评分显著高于A组和B组,差异有统计学意义(P均<0.05).3组患者术后不良反应(恶心、呕吐、寒战、瘙痒和呼吸抑制)发生率比较,差异无统计学意义(P均>0.05).结论 氟比洛芬酯联合纳布啡超前镇痛在LC中可以提供良好的术中镇痛效果,并且能够抑制早期术后疼痛,提高患者术后生活质量,加速康复,联合应用安全性高,可以为腹腔镜下胆囊切除患者围术期镇痛管理提供参考.
Objective To evaluate the clinical efficacy of flurbiprofen axetil combined with nalbuphine for preemptive analgesia in laparoscopic cholecystectomy(LC).Methods Clinical data of 90 patients undergoing LC in Luoyang Cen-tral Hospital from August 2022 to October 2023 were retrospectively selected.They were divided into nalbuphine group(group A,n=30),flurbiprofen exate group(group B,n=30)and nalbuphine combined with flurbiprofen exate group(group C,n=30)according to different narcotic drugs.Pre-analgesic drugs were given 15 min before surgical in-cision.Patients in group A were given intravenous infusion of nalbuphine 0.2 mg/kg,patients in group B were given in-travenous infusion of flurbiprofen ester 2 mg/kg,and patients in group C were given intravenous infusion of nalbuphine 0.2 mg/kg and flurbiprofen ester 2 mg/kg.Visual Analogue Scale(VAS)scores and Ramsay sedation scores were ob-tained 2 h(T1),4 h(T2),12 h(T3)and 24 h(T4)after surgery,the dose of propofol and remifentanil used during sur-gery,the time to recovery after discontinuation of the drug,the score of postoperative recovery quality[assessed by Quality of Recovery-15 Score(QoR-15)scale],and the incidence of postoperative adverse reactions of three groups were compared.Results There was no significant difference in the dosage of propofol and recovery time among 3 groups(both P>0.05).The dosage of remifentanil in group C was lower than that in group A and group B,and the dif-ference was statistically significant(P<0.05).The VAS scores at T1 and T2 time points in group C were lower than those in group A and group B,and the differences were statistically significant(both P<0.05).There was no significant difference in T3 and T4 VAS scores among 3 groups(both P>0.05).There was no significant difference in Ramsay score at T1 to T4 in 3 groups(all P>0.05).The QoR-15 scores in group C were significantly higher than those in group A and group B on the 1st and 3rd day after surgery,the differences were statistically significant(both P<0.05).There was no significant difference in the total incidence of postoperative adverse reactions(nausea,vomiting,chills,pruritus and respiratory depression)among 3 groups(all P>0.05).Conclusion Flurbiprofen axetil combined with nal-buphine can provide good intraoperative analgesia effect in LC,and can inhibit early postoperative pain,improve post-operative quality of life and accelerate recovery.The combined application has high safety,and can provide reference for perioperative analgesia management in patients with laparoscopic cholecystectomy.

Preemptive analgesiaFlurbiprofen axetilNalbuphineLaparoscopic cholecystectomy

刘涛、胡杰

展开 >

新乡医学院,河南 新乡 453003

洛阳市中心医院麻醉科,河南 洛阳 471000

超前镇痛 氟比洛芬酯 纳布啡 腹腔镜胆囊切除术

2024

中外医疗
卫生部医院管理研究所 二十一世纪联合创新医药科学研究院

中外医疗

影响因子:0.909
ISSN:1674-0742
年,卷(期):2024.43(22)